Ocugen Inc.

About Ocugen Inc.

Ocugen Inc. is a fully integrated, patient-centric biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines to improve health and offer hope for patients globally through courageous innovation. Their mission is to address unmet medical needs, particularly in retinal diseases, orthopedic conditions, and infectious diseases like COVID-19.

Products & Services

Vaccines:A novel adenoviral-vectored mucosal COVID-19 vaccine aimed at reducing infection and transmission.

Gene Therapies:A modifier gene therapy platform targeting inherited retinal diseases and other blindness conditions affecting millions.

Cell Therapies:Regenerative cell therapy platform to treat serious conditions like articular cartilage lesions in orthopedic diseases.

Specialties

Gene Therapies for Retinal Diseases Cell Therapies for Orthopedic Conditions Vaccines for Infectious Diseases Modifier Gene Therapy Platform

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 22500000 MR: - FA: 22.5 Million FAN: 22500000	D: 2026-01-23 FD: 2026-01-23	1 investors
2	RT: Equity Offering T: - FT: Equity Offering	A: 22500000 MR: - FA: 22.5 million FAN: 22500000	D: 2026-01-21 FD: 2026-01-21	1 investors
3	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 20000000 MR: - FA: $20 million FAN: 20000000	D: 2025-08-12 FD: 2025-08-12	1 investors
4	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 20000000 MR: - FA: 20 million FAN: 20000000	D: 2025-08-08 FD: 2025-08-08	1 investors
5	RT: Debt T: - FT: Debt	A: 30000000 MR: - FA: 30 million FAN: 30000000	D: 2024-11-06 FD: 2024-11-06	1 investors
6	RT: Public Offering T: - FT: Public Offering	A: 35000000 MR: - FA: $35 million FAN: 35000000	D: 2024-08-02 FD: 2024-08-02	2 investors
7	RT: Public Offering T: - FT: Public Offering	A: 16500000 MR: - FA: 16.5 million FAN: 16500000	D: 2023-05-24 FD: 2023-05-24	1 investors

Registered Direct Offering Latest

2026-01-23

$22.5M

1 investor (Pro only)

Equity Offering 2026-01-21

$22.5M

Registered Direct Offering 2025-08-12

$20.0M

View 6 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Shankar Musunuri

Chairman, CEO and Co-founder

U

Uday Kompella

Co-founder and Director

A

Abhi Gupta

Executive Vice President, Commercial and Business Development

H

Huma Qamar

Chief Medical Officer

R

Ramesh Ramachandran

Chief Accounting Officer

V

Vijay Tammara

Chief Development Officer

View 27 more team members with Pro

Unlock Full Team Directory

Recent News

Ocugen Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised